Award notice Supplies
Leveren van antibiotica, antivirale middelen en antimycotica
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- AZ Alma
Eeklo - Place of performance
- 9900 Eeklo, East Flanders
- Amount awarded
- €618,851 excl. VAT
- Planned end of contract
- 8 December 2028
likely re-tender around June 2028 - Bids received
- 5
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 4 December 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
De opdracht is opgedeeld in percelen. Per perceel worden één of meerdere producten vermeld. Alle percelen kunnen 2 keer stilzwijgend worden verlengd voor een periode van één jaar.
Awarded to
54 lots
- Benzylpenicilline ATC J01CE01
- Flucloxacilline - ATC J01CF05 - PO
- Flucloxacilline - ATC J01CF05 - IV
- Amoxicilline - ATC J01CA04 - PO
- Amoxicilline - ATC J01CA04 - PO - vloeibare vorm
- Amoxicilline - ATC J01CA04 - parenteraal
- Amoxicilline + clavulaanzuur - ATC J01CR02 - PO
- Amoxicilline + clavulaanzuur - ATC J01CR02- PO oplosbaar
- Amoxicilline + clavulaanzuur - ATC J01CR02- PO vloeibare vorm pediatrie
- Amoxicilline + clavulaanzuur - ATC J01CR02- IV - lot1
- Amoxicilline + clavulaanzuur - ATC J01CR02- IV - lot2
- Temocilline - ATC J01CA17- parenteraal
- Piperacilline + Tazobactam - ATC J01CR05- IV
- Cefazoline - ATC J01DB04- parenteraal
- Cefuroxim - ATC J01DC02 - PO
- Cefuroxim - ATC J01DC02 - parenteraal
- Cefotaxim - ATC J01DD01 - parenteraal
- Ceftazidim - ATC J01DD02 - parenteraal
- Ceftriaxone - ATC J01DD04 - parenteraal
- Meropenem - ATC J01DH02 - IV
- Erythromycine - ATC J01FA01 - IV
- Azithromycine - ATC J01FA10 - PO
- Azithromycine - ATC J01FA10 – PO – vloeibare vorm
- Clarithromycine - ATC J01FA09 - PO
- Clarithromycine - ATC J01FA09 - IV
- Clindamycine - ATC J01FF01 - PO
- Clindamycine - ATC J01FF01 - IV
- Ciprofloxacine - ATC J01MA02 - PO
- Ciprofloxacine - ATC J01MA02 - IV
- Moxifloxacine - ATC J01MA14 - PO
- Moxifloxacine - ATC ATC J01MA14 - IV
- Sulfamethoxazol + trimethoprim - ATC J01EE01 - PO
- Sulfamethoxazol + trimethoprim - ATC J01EE01 – PO - vloeibare vorm
- Sulfamethoxazol + trimethoprim - ATC J01EE01 - IV
- Nitrofurantoïne - ATC J01XE01 - PO
- Fosfomycine - ATC J01XX01 - PO
- Amikacine - ATC J01GB06 - IV
- Gentamicine - ATC J01GB03 - IV
- Vancomycine - ATC J01XA01 - IV
- Linezolid - ATC J01XX08 - PO
- Linezolid - ATC J01XX08 - IV
- Rifamycine - ATC J04AB03 - IV
- Nystatine - ATC A07AA02 - PO
- Anidulafungine - ATC J02AX06 - IV
- Fluconazole - ATC ATC J02AC01 - PO
- Fluconazole - ATC J02AC01 - IV
- Voriconazole - ATC J02AC03 - PO
- Voriconazole - ATC J02AC03 - IV
- Metronidazole - ATC J01XD01 - PO
- Metronidazole - ATC J01XD01 - IV
- Aciclovir - ATC J05AB01 - PO
- Aciclovir - ATC J05AB01 - IV
- Palivizumab - ATC J06BD01 - IM
- Sofosbuvir + velpatasvir - ATC J05AP55 - PO
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Leveren Aflibercept (ATC S01LA05) AZ Alma · 29 September 2026 |
Celltrion Healthcare BeLux | €3,300,000 |
| Leveren Omalizumab (ATC R03DX05) AZ Alma · 17 April 2026 |
NOVARTIS PHARMA NV | €250,000 |
| Leveren van paracetamol voor intraveneuze toediening AZ Alma · 6 February 2026 |
B. Braun Medical nv | €482,880 |
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 740253-2024.